This page is part of the FHIR Specification (v5.0.0-snapshot1: Release 5 Snapshot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
. Page versions: R4B R4 R3
| Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative |
Raw JSON (canonical form + also see JSON Format Specification)
Definition for Code System AdverseEventCausalityAssessment
{
"resourceType" : "CodeSystem",
"id" : "adverse-event-causality-assess",
"meta" : {
"lastUpdated" : "2021-12-19T08:15:41.873+11:00",
"profile" : ["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"]
},
"text" : {
"status" : "generated",
"div" : "<div>!-- Snipped for Brevity --></div>"
},
"extension" : [{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "pc"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode" : "draft"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger" : 1
}],
"url" : "http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess",
"identifier" : [{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.4.642.1.1254"
}],
"version" : "5.0.0-snapshot1",
"name" : "AdverseEventCausalityAssessment",
"title" : "AdverseEventCausalityAssessment",
"status" : "draft",
"experimental" : false,
"date" : "2020-12-28T16:55:11+11:00",
"publisher" : "HL7 (FHIR Project)",
"contact" : [{
"telecom" : [{
"system" : "url",
"value" : "http://hl7.org/fhir"
},
{
"system" : "email",
"value" : "fhir@lists.hl7.org"
}]
}],
"description" : "Codes for the assessment of whether the entity caused the event.",
"caseSensitive" : true,
"valueSet" : "http://hl7.org/fhir/ValueSet/adverse-event-causality-assess",
"content" : "complete",
"concept" : [{
"code" : "certain",
"display" : "Certain",
"definition" : "i) Event or laboratory test abnormality, with plausible time relationship to drug intake; ii) Cannot be explained by disease or other drugs; iii) Response to withdrawal plausible (pharmacologically, pathologically); iv) Event definitive pharmacologically or phenomenologically (i.e. an objective and specific medical disorder or a recognized pharmacological phenomenon); or v) Re-challenge satisfactory, if necessary."
},
{
"code" : "probably-likely",
"display" : "Probably/Likely",
"definition" : "i) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Unlikely to be attributed to disease or other drugs; iii) Response to withdrawal clinically reasonable; or iv) Re-challenge not required."
},
{
"code" : "possible",
"display" : "Possible",
"definition" : "i) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Could also be explained by disease or other drugs; or iii) Information on drug withdrawal may be lacking or unclear."
},
{
"code" : "unlikely",
"display" : "Unlikely",
"definition" : "i) Event or laboratory test abnormality, with a time to drug intake that makes a relationship improbable (but not impossible); or ii) Disease or other drugs provide plausible explanations."
},
{
"code" : "conditional-classified",
"display" : "Conditional/Classified",
"definition" : "i) Event or laboratory test abnormality; ii) More data for proper assessment needed; or iii) Additional data under examination."
},
{
"code" : "unassessable-unclassifiable",
"display" : "Unassessable/Unclassifiable",
"definition" : "i) Report suggesting an adverse reaction; ii) Cannot be judged because information is insufficient or contradictory; or iii) Data cannot be supplemented or verified."
}]
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.